Back to Results
First PageMeta Content
Pharmaceutical sciences / Pharmaceutical industry / Pharmaceuticals policy / Drug safety / Food and Drug Administration / Clinical trial / Regulatory requirement / Electronic Common Technical Document / Good manufacturing practice / Clinical research / Research / Health


Guidance Document Submission and Information Requirements for Extraordinary Use New Drugs (EUNDs) Published by authority of the Minister of Health
Add to Reading List

Document Date: 2014-07-02 12:31:12

Open Document

File Size: 316,39 KB

Share Result on Facebook

Company

Health Canada / /

Country

Canada / /

Event

FDA Phase / /

Facility

Publications Brooke Claxton Building / /

/

IndustryTerm

health products / therapeutic product / trial applications / prospective product / innovator/reference drug product / pharmaceutical equivalent / reference drug product / drug product / Generic drug products / food / /

MedicalCondition

disorder / serious disease / /

Organization

HEALTH PRODUCTS AND FOOD BRANCH / federal regulatory authority / /

/

Position

Minister of Health / Minister of Public Works / senior executive officer / General / Minister / scientific officer / /

Product

New Drug / /

Technology

drug development / /

SocialTag